Amgen Inc. (AMGN) PT Lowered to $172.00

Amgen Inc. (AMGN) PT Lowered to $172.00


The firm presently has a "neutral" rating on the medical research company's stock. Citigroup Inc.'s target price points to a potential upside of 1.35% from the stock's current price.



from Biotech News